Peptide therapy on TikTok: gym claims vs. actual science

What did @bigonial_ actually say?

In short: IGF-1 LR3 is overhyped, probably a money grab, and "doesn't build muscle." The creator argues there's "no single study showing it builds meaningful muscle mass" and that any results people report are placebo, better pumps, or improved recovery. They also make the sweeping claim that "the only things that grow you muscle are steroids."

To their credit, they disclosed a financial conflict of interest upfront, admitting they could profit from recommending the peptide but chose not to. That's more transparency than most peptide content on TikTok offers. The core skepticism here is reasonable, even if some of the specifics get sloppy.

Does the science back this up?

Partially, yes, but not as cleanly as the creator suggests. IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1, engineered to have reduced binding to IGF-binding proteins, which theoretically keeps it active in circulation longer. The liver-binding claim the creator makes is a real mechanism, but the conclusion they draw from it is oversimplified.

Human clinical trial data on IGF-1 LR3 specifically for muscle hypertrophy in healthy adults is genuinely thin. Most relevant research involves IGF-1 in disease states, not performance contexts. Fryburg et al. (1995, American Journal of Physiology) showed that local IGF-1 infusion increased forearm muscle protein synthesis, but this was native IGF-1, not LR3, and not in a healthy training population. Rodent studies showing anabolic effects of IGF-1 LR3 (Adams and McCue, 1998, Journal of Applied Physiology) don't translate cleanly to humans. The creator is right that robust human evidence for meaningful muscle gains is missing. They're wrong to imply the mechanism is implausible.

What did they get wrong (or right)?

The biggest factual stumble is the claim that "the only things that grow you muscle are steroids." This is flat-out wrong and the kind of reductive statement that trades nuance for virality. Anabolic steroids are one class of compounds with demonstrated muscle-building effects in humans, but insulin, growth hormone, and certain SARMs have shown anabolic effects in clinical literature too. Even creatine monohydrate has robust evidence for lean mass accretion.

The creator also conflates "no strong evidence it works" with "proven it doesn't work." Those are different claims. Absence of high-quality human RCT data is a legitimate criticism, but it's not the same as a null result. IGF-1 signaling is genuinely central to skeletal muscle hypertrophy (Musaro et al., 2001, Nature Genetics), so dismissing the mechanism entirely is scientifically careless. What they got right: the peptide is being sold aggressively without proportionate evidence, and most users are likely experiencing placebo or nonspecific recovery effects.

What should you actually know?

IGF-1 LR3 sits in a regulatory gray zone. It is not approved by the FDA for muscle building or athletic performance in healthy individuals. It's a research compound, and human pharmacokinetic data for subcutaneous use in performance contexts is limited. That matters before anything else.

Beyond legality, there are safety considerations the creator skipped entirely. IGF-1 signaling is linked to cell proliferation pathways, and theoretical concerns about tumor promotion in susceptible individuals have been raised in the literature, though not confirmed in short-term human use. Sandhu et al. (2002, Journal of the National Cancer Institute) found associations between elevated IGF-1 levels and cancer risk, which is worth knowing before injecting a compound designed to extend IGF-1 activity. The creator's conclusion, save your money and sleep better, is practically sound. But the reasoning they used to get there had gaps that deserve filling in.